Ed C Lavelle Selected Research

Ed C Lavelle Research Topics

Disease

17	Inflammation (Inflammations) 01/2023 - 05/2004
15	Infections 01/2023 - 12/2006
11	Neoplasms (Cancer) 05/2024 - 03/2008
5	Communicable Diseases (Infectious Diseases) 01/2022 - 04/2011
4	Bites and Stings (Sting) 05/2024 - 03/2016
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 07/2006
3	Tuberculosis (Tuberculoses) 01/2020 - 02/2016
2	Pneumococcal Infections 01/2020 - 11/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019 - 01/2019
2	Necrosis 06/2019 - 01/2018
2	Cholera 01/2019 - 08/2015
2	Rheumatoid Arthritis 01/2019 - 02/2013
2	Melanoma (Melanoma, Malignant) 01/2016 - 01/2014
2	Choroidal Neovascularization 04/2014 - 05/2012
2	Macular Degeneration (Age-Related Maculopathy) 04/2014 - 05/2012
2	Whooping Cough (Pertussis) 01/2013 - 12/2006
1	Fibrosis (Cirrhosis) 01/2022
1	Cicatrix (Scar) 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Sepsis (Septicemia) 01/2019
1	Disease Progression 01/2019
1	Multiple Sclerosis 01/2019
1	Glioma (Gliomas) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Rupture 04/2016
1	Eosinophilia 01/2016
1	Carcinogenesis 01/2016
1	Obesity 01/2016
1	Parasitic Diseases (Parasitic Disease) 01/2016
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2016
1	Poliomyelitis (Polio) 08/2015
1	Blindness (Hysterical Blindness) 04/2014
1	Atrophy 04/2014

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 11/2023 - 12/2006
10	CytokinesIBA 01/2023 - 08/2009
7	Interleukin-1 (Interleukin 1)IBA 01/2019 - 12/2006
5	InflammasomesIBA 01/2023 - 10/2010
5	Interleukin-17 (Interleukin 17)IBA 12/2013 - 12/2006
4	AntigensIBA 01/2021 - 05/2014
4	InterleukinsIBA 06/2019 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2010
4	Interleukin-23 (Interleukin 23)IBA 05/2011 - 12/2006
3	PolymersIBA 05/2024 - 03/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2019 - 01/2016
3	Interleukin-33IBA 01/2016 - 07/2009
2	ChitinIBA 05/2024 - 01/2021
2	InterferonsIBA 05/2024 - 01/2019
2	CaspasesIBA 01/2020 - 07/2009
2	ChitosanIBA 06/2019 - 03/2016
2	Interferon Type IIBA 01/2019 - 03/2016
2	LipopolysaccharidesIBA 01/2019 - 05/2004
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 01/2016
2	Vaccine AdjuvantsIBA 03/2016 - 03/2008
2	Interleukin-18 (Interleukin 18)IBA 04/2014 - 05/2012
1	Cancer VaccinesIBA 05/2024
1	Bile Acids and Salts (Bile Acids)IBA 01/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2021
1	Succinic Acid (Succinate)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2020
1	4-hydroxybenzoic acid (p-hydroxybenzoate)IBA 01/2020
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2020
1	IsoenzymesIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 11/2019
1	CathepsinsIBA 01/2019
1	Cholera ToxinIBA 01/2019
1	Drinking WaterIBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	GlycolipidsIBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	cathepsin SIBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Caspase 1 (ICE Protease)IBA 04/2016
1	Sulfhydryl Compounds (Thiols)IBA 04/2016
1	EnzymesIBA 04/2016
1	Particulate MatterIBA 04/2016
1	Cysteine Proteases (Cysteine Protease)IBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Pattern Recognition ReceptorsIBA 01/2016
1	AlarminsIBA 01/2016
1	C-Type Lectins (C-Type Lectin)IBA 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Leucine (L-Leucine)FDA Link 01/2016
1	NucleotidesIBA 01/2016
1	ChemokinesIBA 11/2014
1	OilsIBA 06/2014
1	AntibodiesIBA 05/2014
1	Retinal Pigments (Pigments, Visual)IBA 04/2014
1	Retinaldehyde (Retinal)IBA 04/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	SiliconIBA 01/2014

Therapy/Procedure

4	Therapeutics 05/2024 - 10/2010
3	Immunotherapy 01/2020 - 01/2014
1	Immunomodulation 01/2018
1	Injections 12/2017